Related Experiment Video
Updated: Dec 17, 2025
11:14
Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay
Published on: November 10, 2013
58.6K
p-Cymene metallo-derivatives: An overview on anticancer activity
Shardar Mohammad Hafiz Hassan1, Pranta Ray1, Rajib Hossain1
1Department of Pharmacy, Life Science Faculty, Bangabandhu Sheikh Mujibur Rahman Science and Technology University, Gopalganj-8100, Bangladesh.
Cellular and Molecular Biology (Noisy-Le-Grand, France)
|June 26, 2020
Summary
p-cymene metallo-drugs show significant anticancer potential, offering new therapeutic strategies for cancer. Further research and clinical trials are recommended for their use in cancer chemotherapy combinations.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Oncology
Background:
- Metallo-drugs are increasingly important in cancer therapy, with platinum complexes widely used.
- p-cymene metallo-derivatives are emerging as promising anticancer agents.
Purpose of the Study:
- To review the anticancer mechanisms of p-cymene metallo-drugs.
- To explore their pharmaceutical and biotechnological prospects.
Main Methods:
- Literature review of studies on p-cymene metallo-derivatives.
- Analysis of reported anticancer activities in various test systems.
Main Results:
- p-cymene metallo-derivatives exhibit notable anticancer activities against cancer cells.
- These compounds present diverse mechanisms of action.
Conclusions:
- p-cymene metallo-drugs warrant further investigation for cancer treatment.
- Clinical trials are suggested to evaluate their efficacy in combination chemotherapy.
Related Concept Videos
02:34Inhibition of Cdk Activity
5.4K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.4K
02:57Targeted Cancer Therapies
8.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.5K
01:15Drugs that Stabilize Microtubules
2.5K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.5K